Thrombocytopenia

What is thrombocytopenia?

Platelets are small blood cells produced in the bone marrow that form clots at sites of injury to prevent bleeding. A normal platelet count ranges from 150 to 400 x 10⁹/L. Thrombocytopenia is defined as a platelet count below 150 x 10⁹/L.

Severity determines clinical risk:

• Mild thrombocytopenia (100 to 150 x 10⁹/L) rarely causes spontaneous bleeding and is often discovered incidentally.

• Moderate thrombocytopenia (50 to 100 x 10⁹/L) increases bleeding risk after injury or surgery and warrants investigation.

• Severe thrombocytopenia (below 50 x 10⁹/L) carries significant spontaneous bleeding risk, particularly below 20 x 10⁹/L where life-threatening bleeding becomes a serious concern.

Mild thrombocytopenia typically causes no symptoms. As the count falls, symptoms reflect the impaired clotting capacity:

• Easy or unexplained bruising

• Prolonged bleeding from cuts or minor injuries

• Petechiae, small red or purple pinpoint spots on the skin from tiny bleeds under the surface

• Purpura, larger purple patches from bleeding under the skin

• Nosebleeds or bleeding gums

• Heavy or prolonged menstrual bleeding

• Blood in urine or stools in more severe cases

• In severe thrombocytopenia: spontaneous internal bleeding including intracranial haemorrhage, which is a medical emergency

Thrombocytopenia results from reduced platelet production, increased platelet destruction, or excessive platelet consumption. Common contributing causes include:

• Immune thrombocytopenia (ITP) is the most common cause in healthy adults. The immune system produces antibodies that destroy platelets, causing isolated thrombocytopenia without affecting other blood cell types.

• Viral infections including HIV, hepatitis C, Epstein-Barr virus, and dengue fever directly suppress platelet production or trigger immune-mediated platelet destruction.

• Medications including heparin, certain antibiotics, chemotherapy agents, and some anti-inflammatory drugs cause thrombocytopenia through immune or direct bone marrow suppression mechanisms.

• Liver disease and hypersplenism cause platelet sequestration in an enlarged spleen and reduced thrombopoietin production, both lowering circulating platelet counts.

• Bone marrow disorders including aplastic anaemia, myelodysplastic syndrome, and leukaemia impair platelet production alongside other blood cell types.

• Nutritional deficiencies particularly vitamin B12 and folate impair bone marrow DNA synthesis and reduce platelet production.

• Disseminated intravascular coagulation (DIC) causes rapid consumption of platelets and clotting factors, typically in the context of serious infection, trauma, or malignancy.

• Autoimmune conditions including lupus and antiphospholipid syndrome cause immune-mediated platelet destruction.

Thrombocytopenia is detected directly through a full blood count, with supporting markers identifying the underlying cause.

Blood tests Elfcare's panel includes platelet count alongside key supporting markers:

• Platelet count: the primary marker, measured as part of the full blood count.

• Full blood count: assesses whether thrombocytopenia is isolated or affects other cell lines, which strongly suggests a bone marrow disorder.

• CRP: distinguishes active infection or inflammation from other causes.

• Vitamin B12 and folate: identify nutritional causes of bone marrow suppression.

• Ferritin and iron: provide additional bone marrow nutritional context.

• ALT, AST, ALP, and albumin: assess liver function. Liver disease is a common and frequently overlooked cause of low platelets.

• TSH identifies thyroid dysfunction, which can affect platelet production.

• Uric acid is elevated in hematological malignancy and significant bone marrow pathology.

Why early detection matters

Mild thrombocytopenia discovered incidentally in an otherwise well person often has a benign, self-limiting cause. But the same blood finding can be the first sign of an autoimmune condition, liver disease, nutritional deficiency, or bone marrow disorder requiring prompt treatment. Severe thrombocytopenia without intervention carries a risk of life-threatening bleeding. Early identification allows for risk stratification, timely treatment of reversible causes, and close monitoring of those at higher risk, preventing the serious bleeding complications that undetected or untreated low platelet counts can lead to.

How Elfcare can help

Elfcare's full blood count includes platelet count as standard, making thrombocytopenia a directly detectable finding in every health check. Our panel covers vitamin B12, folate, liver function, CRP, and thyroid markers, providing the context needed to identify the most common underlying causes and distinguish mild incidental findings from those requiring urgent specialist assessment.

If our blood tests identify thrombocytopenia or related findings, we take care of further diagnostics or refer you to the appropriate specialist.